Novel mitochondria penetrating peptide for live-cell long-term tracking of mitochondria

A novel mitochondria penetrating peptide (MPP) that can permeate the mitochondrial membrane for long-term tracking of mitochondria is reported. In-vitro studies indicate persistence of the MPP probe, low cytotoxicity, and high bio-compatibility.

[1]  D. Green,et al.  Enzymatic Cleavage of Branched Peptides for Targeting Mitochondria. , 2018, Journal of the American Chemical Society.

[2]  S. Kelley,et al.  Delivery and Release of Small-Molecule Probes in Mitochondria Using Traceless Linkers. , 2017, Journal of the American Chemical Society.

[3]  H. Sugiyama,et al.  Creation of a Synthetic Ligand for Mitochondrial DNA Sequence Recognition and Promoter-Specific Transcription Suppression. , 2017, Journal of the American Chemical Society.

[4]  Carol S. Lim,et al.  Delivery of drugs and macromolecules to the mitochondria for cancer therapy. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[5]  S. Kelley,et al.  Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria. , 2016, Accounts of chemical research.

[6]  M. Haigis,et al.  Mitochondria and Cancer , 2016, Cell.

[7]  Marco Pirisinu,et al.  Novel cell‐penetrating peptide targeting mitochondria , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  S. Kelley,et al.  Molecular vehicles for mitochondrial chemical biology and drug delivery. , 2014, ACS chemical biology.

[9]  M. Minden,et al.  Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells. , 2011, Chemistry & biology.